New lifeline for patients with inoperable neuroendocrine cancers
Friday, March 11, 2016 - 11:00
in Health & Medicine
A novel drug proven to reduce the risk of disease progression by 79% offers new hope to patients with inoperable metastatic advanced midgut neuroendocrine cancer.